Dose-ranging Study to Evaluate Antibody Response to G17DT in Patients With Gastric Cancer
Clinical trial NCT02521649 · COMPLETED
Trial details
- NCT number
- NCT02521649
- Sponsor
- Cancer Advances Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 1998-09-01
- Primary completion
- 2001-01-01
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.